treatment effects of family based cognitive therapy in children and adolescents with obsessive compulsive disorder

Conditions: Obsessive-Compulsive Disorder in Children; Obsessive-Compulsive Disorder in Adolescence

Summary: to investigate the benefits and harms, and the neural and neurocognitive mediators of treatment response, in family-based cognitive behavioural therapy versus family-based psychoeducation and relaxation training in children and adolescents with obsessive compulsive disorder. the aim is to conduct this investigation in an optimal trial design with the lowest possible risk of bias.

obsessive-compulsive disorder is the fourth most common psychiatric disorder, affecting 1-3% of children and adolescents globally. the recommended first-line treatment is cognitive behavioral therapy with exposure and response prevention. yet, more than 40% of patients do not, or only partially, benefit from therapy. a better understanding of the mechanisms underlying response to cognitive behavioral therapy is needed to improve treatment. in the tecto study, we will conduct a combined randomized clinical trial and longitudinal case-control study to elucidate how neural, cognitive, emotional, and neuroendocrine factors moderate and mediate treatment response. at baseline, 128 children and adolescents with obsessive-compulsive disorder will be compared to 128 healthy control participants to map neurobiological, cognitive, and emotional markers of obsessive-compulsive disorder. after baseline assessment, patients are randomly assigned to 16 weeks of either cognitive behavioral therapy with exposure and response prevention or an active control treatment with psychoeducation and relaxation training. this design allows us to test how factors that are specific to cognitive behavioral therapy (e.g. exposure and response prevention) contribute to observed treatment effects. our primary outcome is ocd symptom severity measured with the children's yale-brown obessive-compulsive scale. secondary outcomes are health-related quality of life and negative treatment effects. to detect neural and cognitive mediators of treatment, we will measure brain structure and function, and cognitive performance, at baseline and end-of-treatment. furthermore, we will monitor a range of therapeutic, emotional, family, and neuroendocrine factors before, during, and after treatment. we expect that findings from tecto will have important theoretical implications and will help refine our understanding of ocd as a heterogeneous and multidimensional disorder. finally, we expect that our findings will contribute significantly to the improvement of psychotherapy and development of more targeted interventions for pediatric obsessive-compulsive disorder, which can minimize the use of medication, prevent chronicity, and reduce the substantial socioeconomic burden of the disorder.

Eligibility criteria:
inclusion criteria: * ocd diagnosis as primary diagnosis, meeting the criteria for international classification of diseases 10 (icd-10) f42, verified with a semi-structured psychopathological interview using schedule for affective disorders and schizophrenia for school-aged children, present and lifetime version (k-sads-pl). * children's yale-brown obsessive-compulsive scale (cy-bocs) entry score ≥16, a cut-off score used in previous studies. * age 8 through 17 years (both inclusive). * signed informed consent. exclusion criteria: * comorbid illness that contraindicates trial participation: pervasive developmental disorder not including asperger's syndrome (icd-10 f84.0-84.4 + f84.8-84.9), schizophrenia/paranoid psychosis (icd-10 f20-25 + f28-29), mania or bipolar disorder (icd-10 f30 and f31), depressive psychotic disorders (f32.3 + f33.3), substance dependence syndrome (icd-10 f1x.2). * intelligence quotient \<70. * treatment with cognitive behavioural therapy (cbt), serotonin reuptake inhibitors, or other antidepressant medication or antipsychotic medication within the last 6 months prior to trial entry. * for mri-scanning: * metal braces on teeth or metal implants; * any known brain pathology; * history of severe head-trauma (icd-10 s6-s9); * pregnancy.

Keywords: ocd